LADFX | Developing Growth Fund Class F | Lord Abbett

Tracked Funds

You have 0 funds on your mutual fund watch list.

Begin by selecting funds to create a personalized watch list.

(as of 12/05/2015)

Pending Orders

You have 0 items in your cart.

Subscribe and order forms, fact sheets, presentations, and other documents that can help advisers grow their business.

Developing Growth Fund

Track this Fund
Add to Hypo Tool

Summary

Summary

What is the Developing Growth Fund?

The Fund seeks to deliver long-term growth of capital by investing primarily in stocks of small U.S. companies.

Fund Basicsas of 10/31/2025

Total Net Assets
$2.08 B
Inception Date
09/28/2007
Dividend Frequency
Annually
Fund Gross Expense Ratio
0.79%
Fund Net Expense Ratio
0.79%
Number of Holdings
82

Fund Expense Ratio :

Gross 0.79%

Net 0.79%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception 09/28/2007
w/o sales charge 17.97% 9.92% 13.63% 1.46% 10.97% 9.65%
Lipper Category Avg. Small-Cap Growth Funds 9.61% 1.43% 11.39% 4.51% 9.85% -
Russell 2000® Growth Index 14.48% 5.11% 13.54% 5.31% 9.18% 8.47%
w/ sales charge 17.97% 9.92% 13.63% 1.46% 10.97% 9.65%

Fund Expense Ratio :

Gross 0.79%

Net 0.79%

Fund Expense Ratio :

Gross 0.79%

Net 0.79%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception 09/28/2007
w/o sales charge 12.62% 13.65% 14.27% 3.51% 10.82% 9.46%
Lipper Category Avg. Small-Cap Growth Funds 6.12% 7.59% 14.09% 6.85% 10.28% -
Russell 2000® Growth Index 11.65% 13.56% 16.68% 8.41% 9.91% 8.40%

Fund Expense Ratio :

Gross 0.79%

Net 0.79%

TEN LARGEST HOLDINGS as of 10/31/2025View Portfolio

Holding Assets
Credo Technology Group Holding Ltd 3.7%
Comfort Systems USA Inc 3.5%
Guardant Health Inc 3.1%
Insmed Inc 2.3%
Mirion Technologies Inc 2.1%
Kratos Defense & Security Solutions Inc 2.1%
Modine Manufacturing Co 2.0%
Carpenter Technology Corp 2.0%
Argan Inc 1.9%
Bridgebio Pharma Inc 1.9%

INVESTMENT TEAM

F. Thomas O'Halloran
F. Thomas O'Halloran, CFA, J.D.

Partner, Portfolio Manager

38 Years of Industry Experience

Matthew R. DeCicco
Matthew R. DeCicco, CFA

Partner, Director of Equities

26 Years of Industry Experience

Vernon Bice
Vernon Bice, CMT

Portfolio Manager

24 Years of Industry Experience

Benjamin Ebel
Benjamin Ebel

Senior Managing Director, Portfolio Manager

33 Years of Industry Experience

Supported By 8 Investment Professionals with 19 Years Avg. Industry Experience

Your Representative

To contact your representative, enter your zip code and select your channel below.

Performance

Performance

Fund Expense Ratio :

Gross 0.79%

Net 0.79%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception 09/28/2007
w/o sales charge 17.97% 9.92% 13.63% 1.46% 10.97% 9.65%
Lipper Category Avg. Small-Cap Growth Funds 9.61% 1.43% 11.39% 4.51% 9.85% -
Russell 2000® Growth Index 14.48% 5.11% 13.54% 5.31% 9.18% 8.47%
w/ sales charge 17.97% 9.92% 13.63% 1.46% 10.97% 9.65%

Fund Expense Ratio :

Gross 0.79%

Net 0.79%

Fund Expense Ratio :

Gross 0.79%

Net 0.79%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception 09/28/2007
w/o sales charge 12.62% 13.65% 14.27% 3.51% 10.82% 9.46%
Lipper Category Avg. Small-Cap Growth Funds 6.12% 7.59% 14.09% 6.85% 10.28% -
Russell 2000® Growth Index 11.65% 13.56% 16.68% 8.41% 9.91% 8.40%

Fund Expense Ratio :

Gross 0.79%

Net 0.79%

Year Fund Returns Russell 2000® Growth Index
2024 22.12% 15.15%
2023 8.61% 18.66%
2022 -35.96% -26.36%
2021 -2.54% 2.83%
2020 72.81% 34.63%
2019 32.14% 28.48%
2018 5.22% -9.31%
2017 30.12% 22.17%
2016 -2.57% 11.32%
2015 -8.70% -1.38%
2014 3.45% -
2013 57.61% -
2012 10.63% -
2011 -1.41% -
2010 36.93% -
2009 47.37% -
2008 -47.35% -
Year Q1 Q2 Q3 Q4
2025 -17.68% 20.28% 13.75% -
2024 12.69% 0.98% 6.35% 0.91%
2023 8.33% 3.27% -12.90% 11.46%
2022 -19.22% -21.11% 0.60% -0.11%
2021 1.68% 2.91% -3.65% -3.34%
2020 -16.92% 40.68% 16.00% 27.47%
2019 27.04% 9.16% -11.33% 7.47%
2018 7.16% 15.03% 12.19% -23.92%
2017 8.35% 4.13% 7.12% 7.67%
2016 -10.29% 2.22% 10.93% -4.23%
2015 7.19% 2.66% -15.66% -1.63%
2014 1.71% 0.22% -5.70% 7.62%
2013 13.61% 10.06% 18.84% 6.07%
2012 12.23% -2.65% 5.67% -4.18%
2011 10.29% 1.56% -20.83% 11.17%
2010 8.29% -7.89% 16.56% 17.77%
2009 -2.07% 24.38% 14.27% 5.87%
2008 -21.77% 6.70% -11.74% -28.54%

NAV Historical Prices

Date Net Asset Value

Portfolio

Portfolio

Portfolio Details as of 10/31/2025

Total Net Assets
$2.08 B
Number of Holdings
82
Weighted Average Market Cap.
13.3 B
P/B Ratio
10.0x
P/E Ratio
50.7x

Dividends & Cap Gains

Dividends & Cap Gains

Dividend Payments

For
YTD Dividends Paidas of 12/05/2025
$0
Dividend Frequency
Annually
Record Date Ex-Dividend Date Reinvest & Payable Date Dividend Reinvest Price
11/25/2024 11/26/2024 11/26/2024 $0.03260 $26.28

Capital Gains Distributions

For
Record Date Reinvest & Payable Date Long-term Short-term * Total Reinvest Price
11/22/2021 11/23/2021 $3.3406 - $3.3406 $29.67

Fees & Expenses

Fees & Expenses

Expense Ratioas of 11/30/2025

Fund Gross Expense Ratio 0.79%
Fund Net Expense Ratio 0.79%

Fund Documents

Fund Documents

0Documents selected
Portfolio Holdings 1Q
Publish Date:11/03/2015
Portfolio Holdings 3Q
Publish Date:11/03/2015
Summary Prospectus
Publish Date:11/03/2015
Statutory Prospectus
Publish Date:11/03/2015
SAI
Publish Date:11/03/2015
2025 Annual Tailored Shareholder Report
Publish Date:11/03/2015
Fact Sheet
Publish Date:11/03/2015
Commentary
Publish Date:11/03/2015
Fund Story
Publish Date:11/03/2015
* includes items 7-11 of form N-CSR as required, if any.

To order literature visit full website

You may add to your cart by selecting quantities in each row below.

No rows selected. Please Go back and select at least one fund document

 
Quantity
Quantity
Remove
Remove

The Russell 2000® Growth Index measures the performance of those Russell 2000 companies with higher price-to-book ratios and higher forecasted growth values.

Select funds to run a Morningstar Hypothetical Report.